The European Citizens' Initiative scheme permits a minimum of 1 million citizens from at least a quarter of the EU Member States to ask the European Commission to propose legislation. The organisers of a successful petition are invited to present their initiative at a public hearing in the European Parliament.
On 3 March 2015, the third such initiative, Stop Vivisection, signed by 1,173,131 citizens, was submitted to the Commission. 1, 2 It said that: Considering clear ethical objections to animal experiments and solid scientific principles that invalidate the "animal model" for predicting human response, we urge the European Commission to abrogate Directive 2010/63/EU on the protection of animals used for scientific purposes and to present a new proposal that does away with animal experimentation and instead makes compulsory the use -in biomedical and toxicological research -of data directly relevant for the human species.
A public hearing, organised by the European Parliament's Committee on Agriculture and Rural Development, in association with the Committee on Petitions, the Committee on Environment, Public Health and Food Safety, and the Committee on Industry, Research and Energy, took place in Brussels on 11 May 2015. 3 The initiative's organisers, André Ménache, Gianni Tamino and Claude Reiss, were invited to present their views, followed by Ray Greek of Americans for Medical Advancement, Emily McIvor of Humane Society International, and Françoise Barré-Sinoussi, who won the Nobel Prize in 2008 for her contribution to the discovery of HIV. There are various ways of looking into what took place at the hearing. 3, 4 Before the public hearing, the animal research community had wasted no time in expressing their total opposition to the initiative. For example, on 4 March 2015, a Statement supporting European Directive 2010/63/EU ("Directive") on the protection of animals used for scientific purposes was issued via The Wellcome Trust, endorsed by 171 organisations in the UK, 5 and could be downloaded in Bulgarian, Croatian, Czech, Dutch, Estonian, French, German, Greek, Hungarian, Italian, Latvian, Lithuanian, Maltese, Polish, Portuguese, Romanian, Slovak, Slovene and Spanish. The statement said that: The Directive is vital to ensure that necessary research involving animals can continue whilst requiring enhanced animal welfare standards, since The use of animals in research has facilitated major breakthroughs in medicine which have transformed human and animal health. We support research using animals where alternative methods are not available, where the potential benefits to health are compelling, and where acceptable ethical and welfare standards can be met. The Directive has enhanced animal welfare standards and introduced the concepts of refinement, replacement and reduction ('3Rs') across the EU, while ensuring Europe remains a world leader in biomedical research. The 'Stop Vivisection' Citizens' Initiative must be opposed by the European Parliament and the Commission -repealing the Directive would represent a major step backwards both for animal welfare in the EU and for Europe's leading role in advancing human and animal health.
This statement was supported by the League of European Research Universities (LERU), 6 and there are many other statements of opposition to the Citizens' Initiative on the Internet. Not surprisingly, the Internet is also rich in adverse comments on the public hearing itself, saying, for example, "Stop Vivisection Initiative fails to impress at EU hearing" (Speaking of Research 7 ), and "MEPs unconvinced by European Citizens' Initiative on vivisection" (EurActiv 8 ).
An editorial was published in Nature, 9 which included the following statement: For too long, activists have been left to dominate animalresearch debates in many European countries.
Their frequently inaccurate declarations -along with their not-infrequent physical attacks and death threats -have gone largely unchallenged by the scientific community and by the agencies and
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The European Commission's considerate response to the controversial European Citizens' Stop Vivisection Initiative promises to accelerate progress toward eliminating the need for animal experimentation in research and testing politicians who support the community's work. By any reasonable standards, these assertions are unacceptable. Very, very few, if any, of the 1,1717,131 individuals who signed the Stop Vivisection Initiative, and in particular those who organised it, would ever have been involved in physical attacks or death threats, and those who support animal experimentation are no less prone to making "inaccurate declarations" than those who oppose it. It is also significant that the statement organised by The Wellcome Trust was available for signature on 4 March 2015, i.e. one day after the Citizens' Initiative had been received by the Commission. 10 This hardly supports Nature's assertion that the declarations of animal welfare activists "have gone largely unchallenged".
The Nature editorial says that the Stop Vivisection Initiative "has been panicking European research since it was first proposed", but, while it may have raised hope in some quarters and fear in others, there was never any likelihood whatsoever that the EU would do away with animal experimentation altogether and immediately. Nevertheless, the Citizens' Initiative highlights two important points: many animal models are not valid for predicting human responses, and biomedical research and testing do desperately need procedures which are more-directly relevant for the human species. If only The Wellcome Trust and its supporters could more readily acknowledge this, biomedical research and medicine would experience a new dawn, to the benefit of humans and animals alike.
The Commission published its response to the Stop Vivisection Initiative on 3 June 2015, 11 and this led to another set of rather strident headlinesranging from dismissive comments by some animal researchers, to outrage by supporters of the initiative. For example, Gabi Zimmer, President of the Confederal Group of the European United Left/ Nordic Green Left (GUE/NGL) in the Euro pean Parl iament, said that the Commission had "only expressed vague intentions and paid lip service to the initiative, rather than undertaking to start a legislative procedure, and intended neither to invest additional funds in non-animal research from the Horizon 2020 budget nor to carry out an early review of EU legislation on animal experiments". 12 The European Parliament's Intergroup on the Welfare and Conservation of Animals also expressed disappointment at the Commission's response, 13 but made the following incisive comment: An EU strategy is necessary to promote innovation and uptake of more humane state-of-the-art methods. This should also contribute to a paradigm shift to stop relying on the use of animals as the golden rule and recognise that advancing medical progress, research and innovation is possible with methods which do not rely on animals.
Conversely, a set of experts selected by the Science Media Centre 14 made statements in favour of the continuation of animal experimentation, albeit with some recognition of the Three Rs.
So, where does all this leave us? In my opinion, the Commission's response to the Stop Vivisection Initiative is well-considered, well-written and constructive, and the organisers of the Citizens' Initiative should feel that all the effort put into collecting the signatures in support of it was truly worthwhile.
The Commission's response says that the EU shares the conviction of the Citizens' Initiative that animal experimentation should be phased out, and refers to the embedding of animal welfare in the Treaty on which the EU functions. However, while it is recognised that animal studies have historically been key to the development of ways to prevent and treat human and animal diseases, and while animal models have limitations as well as strengths, some use of animals continues to be necessary. Nevertheless, the focus of Directive 2010/ 63/EU, now transposed into the laws of all the Member States, is fully on the Three Rs, and the Commission supports the development of non-animal approaches via the EU Framework Programme, and their validation via EURL-ECVAM. The response also recognises the importance of the work of the European Chemicals Agency (ECHA), the European Medicines Agency (EMA), and the European Food Safety Authority (EFSA), and of international co-operation via the OECD and regulatory and validation authorities in Brazil, Canada, Japan, South Korea and the USA.
The response then outlines four actions in relation to the Citizens' Initiative, "to accelerate the development and uptake of non-animal approaches in research and testing":
1. Accelerating progress in the Three Rs through knowledge sharing, since "Relevant knowledge is wide-ranging and can include scientific under standing of fundamental biological processes, how to refine animal experiments to minimise potential pain and suffering, how to optimally design non-animal approaches to tackle research questions or assess the safety of a substance, or how to characterise and standardise novel models to ensure that they are fit-for-purpose." Action 1 will involve "building on existing activities of the Commission, relevant EU agencies and OECD; the Commission will analyse technologies, information sources and networks from all relevant sectors with potential impact on the advancement of the Three Rs, and will present by end 2016 an assessment of options to enhance knowledge sharing among all relevant parties."
Development, validation and implementation of new alternative approaches. In Action 2,
"the Commission will continue to support the development, validation and implementation of alternative approaches for regulatory and research use. This will include close co-operation between the Commission, Member States and international organisations and be supported, as appropriate, by EU programmes."
3. Enforcement of compliance with the Three Rs principle and alignment of relevant sector legislation; "in line with Directive 2010/63/EU, sector legislation and related guidance should reflect the requirement to use non-animal approaches as soon as they are validated and accepted for regulatory purposes. In Action 3, the Commission will actively monitor compliance with the Directive, in particular the Three Rs principle, and with the relevant obligations in sector legislation to use available alternatives. The Commission will also actively monitor the correct enforcement by all Member States. By the end of 2016, the Commission will examine regulatory requirements in the relevant sector legislation mandating animal testing to assess if the legislative text enables an efficient up-take of available alternative approaches and the Commission will ensure that future proposals for relevant sector legislation will reflect the rules on the protection of animals used for scientific purposes."
4.
Engaging in a dialogue with the scientific community. The aim of Action 4 will be "to facilitate an efficient dialogue", so, by the end of 2016, "the Commission will organise a conference engaging the scientific community and relevant stakeholders in a debate on how to exploit the advances in science for the development of scientifically valid non-animal approaches and advance towards the goal of phasing out animal testing. On that occasion, the Commission will also report progress on actions 1, 2 and 3."
That is all very promising, and it is to be hoped that genuine progress will be made so that animal models of dubious value will be replaced, and valid non-animal procedures and testing strategies will be put in place, which, in the words of the Citizens' Initiative, will provide data directly relevant for the human species. The Commission and the animal welfare movement will not be able to achieve that progress on their own. It will be essential that the scientific community and the relevant industries also demonstrate their genuine and practical commitment to the Three Rs, by highlighting and tackling the outstanding need to replace animal experiments with scientifically-valid and humanrelevant alternatives as soon as is practicably possible. 
